Ophthalmic manifestations are associated with reduced tear lymphotoxin-α levels in chronic ocular graft-versus-host disease

Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD)

(2020) Bohao Hu et al.   Ocular Surface

Evaluation of Tear Protein Markers in Dry Eye Disease with Different LT-alpha Expression Levels

(2020) Haiyan Chen et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

The role of lymphotoxin-α in rheumatoid arthritis

(2018) Tomohiro Hirose et al.   INFLAMMATION RESEARCH

Tear Cytokines as Biomarkers for Chronic Graft-versus-Host Disease

(2015) Ji Won Jung et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

(2015) Madan H. Jagasia et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Lymphotoxin and TNF: How it all began—A tribute to the travelers

(2014) Nancy H. Ruddle   CYTOKINE & GROWTH FACTOR REVIEWS

Ocular Graft-versus-Host Disease: A Review

(2013) Hasanain Shikari et al.   SURVEY OF OPHTHALMOLOGY

In Vivo Depletion of Lymphotoxin-Alpha Expressing Lymphocytes Inhibits Xenogeneic Graft-versus-Host-Disease

(2012) Eugene Y. Chiang et al.   PLoS One

Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey

(2011) B. B. Aggarwal et al.   BLOOD

Soluble lymphotoxin is an important effector molecule in GVHD and GVL

(2009) K. A. Markey et al.   BLOOD

Graft-versus-host disease

(2009) James LM Ferrara et al.   LANCET

Targeted depletion of lymphotoxin-α–expressing TH1 and TH17 cells inhibits autoimmune disease

(2009) Eugene Y Chiang et al.   NATURE MEDICINE